Technical Review Committee (TRC)

The TRC provides external validation of ICAV compounds and designs drug development pathways for promising leads. Composed of industry experts, the TRC’s drug development experience is an essential component of undertaking translational research. TRC evaluates lead compounds and builds a development plan encompassing all aspects of the drug development process including pre-clinical proof of efficacy, toxicology, pharmacology, formulation development and manufacturing, and clinical development.

Theo Anucha, BPharm, PhD
Formulation and Manufacturing

Isobel Ralston, PhD
Pre-Clinical Development

Miklos Shultz, PhD
Clinical Design and Biostatistics

Saul Ship, PhD
Market Analysis

Anne Tomalin, BA, BSc
Regulatory Affairs